Filing Flows

Filing Flows › Fate Therapeutics (FATE) › Who owns the stock

Who owns Fate Therapeutics (FATE) stock

142 funds reported Fate Therapeutics (FATE) shares in their latest 13F filings, worth $202M in all. The largest holder is Redmile Group, LLC ($34.8M). Last quarter 81 funds added to their stakes and 58 cut them.

Largest holders of FATE (13F)Largest holders of FATE (13F)Redmile Group, LLC$34.8MBlackRock$19.7MVanguard Portfolio Management LLC$12.3MVanguard Capital Management LLC$12.0MAcadian Asset Management LLC$11.7MAQR Capital Management LLC$10.4MTwo Sigma Investments, LP$9.7MVanguard Group$8.8MRenaissance Technologies LLC$8.1MJohnson & Johnson$8.0M

Largest holders (13F)

FundSharesValueChangeQuarter
Redmile Group, LLC12,872,946$34.8Munchanged2026-06-30
BlackRock7,298,895$19.7Mdecrease2026-06-30
Vanguard Portfolio Management LLC4,545,893$12.3Mincrease2026-06-30
Vanguard Capital Management LLC4,445,536$12.0Mincrease2026-06-30
Acadian Asset Management LLC4,351,250$11.7Mincrease2026-06-30
AQR Capital Management LLC3,837,229$10.4Mincrease2026-06-30
Two Sigma Investments, LP3,589,863$9.7Mincrease2026-06-30
Vanguard Group8,971,347$8.8Mincrease2025-12-31
Renaissance Technologies LLC2,983,268$8.1Mincrease2026-06-30
Johnson & Johnson3,379,064$8.0Munchanged2026-09-30
Millennium Management LLC2,433,978$6.6Mnew2026-06-30
Goldman Sachs Group2,049,187$5.5Mincrease2026-06-30
Geode Capital Management, LLC1,322,013$3.6Mdecrease2026-06-30
Assenagon Asset Management S.A.1,311,765$3.1Mincrease2026-09-30
T. Rowe Price Investment Management1,080,320$2.9Mnew2026-06-30

Fate Therapeutics' latest quarter

Fate Therapeutics, Q2 2026: revenue $2.1M (+9% year over year), net loss $30.2M, operating cash flow −$23.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most FATE stock?

By the latest 13F filings: Redmile Group, LLC ($34.8M); BlackRock ($19.7M); Vanguard Portfolio Management LLC ($12.3M); Vanguard Capital Management LLC ($12.0M); Acadian Asset Management LLC ($11.7M).

What is the short interest in FATE?

10,618,410 shares were sold short at the 2026-10-15 settlement, -1.31% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.